Optimized timing of CT scans on the basis of hazard of recurrence resulted in follow-up schedule options where CT is performed more sparsely than in the NCCN guidelines during adjuvant imatinib administration and more frequently , at approximately @-month intervals , during the first @ years that follow imatinib discontinuation when the risk of recurrence was the greatest .